Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Multidisciplinary approach to the treatment of obese adolescents: effects on cardiovascular risk factors, inflammatory profile, and neuroendocrine regulation of energy balance.

Dâmaso AR, de Piano A, Campos RM, Corgosinho FC, Siegfried W, Caranti DA, Masquio DC, Carnier J, Sanches Pde L, Leão da Silva P, Nascimento CM, Oyama LM, Dantas AD, de Mello MT, Tufik S, Tock L.

Int J Endocrinol. 2013;2013:541032. doi: 10.1155/2013/541032. Epub 2013 Oct 27.

2.

Negative correlation between neuropeptide Y/agouti-related protein concentration and adiponectinemia in nonalcoholic fatty liver disease obese adolescents submitted to a long-term interdisciplinary therapy.

de Piano A, Tock L, Carnier J, Oyama LM, Oller do Nascimento CM, Martinz AC, Foschini D, Sanches PL, Ernandes RM, de Mello MT, Tufik S, Dâmaso AR.

Metabolism. 2010 May;59(5):613-9. doi: 10.1016/j.metabol.2009.09.003. Epub 2009 Nov 26.

PMID:
19942238
3.

Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.

Sanches PL, de Piano A, Campos RM, Carnier J, de Mello MT, Elias N, Fonseca FA, Masquio DC, da Silva PL, Corgosinho FC, Tock L, Oyama LM, Tufik S, Dâmaso AR.

J Clin Lipidol. 2014 May-Jun;8(3):265-72. doi: 10.1016/j.jacl.2014.02.007. Epub 2014 Mar 2.

PMID:
24793347
4.

Hyperleptinemia in obese adolescents deregulates neuropeptides during weight loss.

Dâmaso AR, de Piano A, Sanches PL, Corgosinho F, Tock L, Oyama LM, Tock L, do Nascimento CM, Tufik S, de Mello MT.

Peptides. 2011 Jul;32(7):1384-91. doi: 10.1016/j.peptides.2011.04.025. Epub 2011 May 6.

5.

The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.

Masquio DC, de Piano A, Campos RM, Sanches PL, Carnier J, Corgosinho FC, Netto BD, Carvalho-Ferreira JP, Oyama LM, Nascimento CM, de Mello MT, Tufik S, Dâmaso AR.

Br J Nutr. 2015 Jun 28;113(12):1920-30. doi: 10.1017/S0007114515001129. Epub 2015 Apr 24.

PMID:
25907896
6.

The role of pro/anti-inflammatory adipokines on bone metabolism in NAFLD obese adolescents: effects of long-term interdisciplinary therapy.

Campos RM, de Piano A, da Silva PL, Carnier J, Sanches PL, Corgosinho FC, Masquio DC, Lazaretti-Castro M, Oyama LM, Nascimento CM, Tock L, de Mello MT, Tufik S, Dâmaso AR.

Endocrine. 2012 Aug;42(1):146-56.

PMID:
22315014
7.

Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease.

de Piano A, Prado WL, Caranti DA, Siqueira KO, Stella SG, Lofrano M, Tock L, Cristofalo DM, Lederman H, Tufik S, de Mello MT, Dâmaso AR.

J Pediatr Gastroenterol Nutr. 2007 Apr;44(4):446-52.

PMID:
17414142
8.

The role of nutritional profile in the orexigenic neuropeptide secretion in nonalcoholic fatty liver disease obese adolescents.

de Piano A, Tock L, Carnier J, Foschini D, Sanches Pde L, Corrêa FA, Oyama LM, do Nascimento CM, Lederman HM, Ernandes R, de Mello MT, Tufik S, Dâmaso A.

Eur J Gastroenterol Hepatol. 2010 May;22(5):557-63. doi: 10.1097/MEG.0b013e3283346df2.

PMID:
20164781
9.

Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.

de Piano A, de Mello MT, Sanches Pde L, da Silva PL, Campos RM, Carnier J, Corgosinho F, Foschini D, Masquio DL, Tock L, Oyama LM, do Nascimento CM, Tufik S, Dâmaso AR.

Eur J Gastroenterol Hepatol. 2012 Nov;24(11):1313-24.

PMID:
22932160
10.

Cut-off values of waist circumference to predict metabolic syndrome in obese adolescents.

Masquio DC, Ganen Ade P, Campos RM, Sanches Pde L, Corgosinho FC, Caranti D, Tock L, de Mello MT, Tufik S, Dâmaso AR.

Nutr Hosp. 2015 Apr 1;31(4):1540-50. doi: 10.3305/nh.2015.31.4.8442.

11.

Short- and long-term beneficial effects of a multidisciplinary therapy for the control of metabolic syndrome in obese adolescents.

Caranti DA, de Mello MT, Prado WL, Tock L, Siqueira KO, de Piano A, Lofrano MC, Cristofalo DM, Lederman H, Tufik S, Dâmaso AR.

Metabolism. 2007 Sep;56(9):1293-300.

PMID:
17697875
12.

The role of pro-inflammatory and anti-inflammatory adipokines on exercise-induced bronchospasm in obese adolescents undergoing treatment.

da Silva PL, de Mello MT, Cheik NC, Sanches PL, Piano A, Corgosinho FC, Campos RM, Carnier J, Inoue D, do Nascimento CM, Oyama LM, Tock L, Tufik S, Dâmaso AR.

Respir Care. 2012 Apr;57(4):572-82. doi: 10.4187/respcare.01307. Epub 2011 Oct 13.

13.

Obese adolescents with eating disorders: analysis of metabolic and inflammatory states.

Carnier J, Sanches Pde L, da Silva PL, de Piano A, Tock L, Campos RM, Corgosinho FC, Corrêa FA, Masquio D, do Nascimento CM, Oyama LM, Ernandes RH, de Mello MT, Tufik S, Dâmaso AR.

Physiol Behav. 2012 Jan 18;105(2):175-80. doi: 10.1016/j.physbeh.2011.08.014. Epub 2011 Aug 17.

PMID:
21871909
14.

Dietary determinants of hepatic steatosis and visceral adiposity in overweight and obese youth at risk of type 2 diabetes.

Mollard RC, Sénéchal M, MacIntosh AC, Hay J, Wicklow BA, Wittmeier KD, Sellers EA, Dean HJ, Ryner L, Berard L, McGavock JM.

Am J Clin Nutr. 2014 Apr;99(4):804-12. doi: 10.3945/ajcn.113.079277. Epub 2014 Feb 12.

15.

Aerobic plus resistance training was more effective in improving the visceral adiposity, metabolic profile and inflammatory markers than aerobic training in obese adolescents.

Dâmaso AR, da Silveira Campos RM, Caranti DA, de Piano A, Fisberg M, Foschini D, de Lima Sanches P, Tock L, Lederman HM, Tufik S, de Mello MT.

J Sports Sci. 2014;32(15):1435-45. doi: 10.1080/02640414.2014.900692. Epub 2014 Apr 14.

PMID:
24730354
16.

The role of PAI-1 and adiponectin on the inflammatory state and energy balance in obese adolescents with metabolic syndrome.

Corgosinho FC, de Piano A, Sanches PL, Campos RM, Silva PL, Carnier J, Oyama LM, Tock L, Tufik S, de Mello MT, Dâmaso AR.

Inflammation. 2012 Jun;35(3):944-51. doi: 10.1007/s10753-011-9397-2.

PMID:
22038064
17.

Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.

Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Pennell CE, de Klerk N, Oddy WH, Shipman P, Adams LA.

Hepatology. 2011 Mar;53(3):800-9. doi: 10.1002/hep.24097.

PMID:
21374659
18.

SSA 04-3 LEPTIN/ADIPONECTIN IN CARDIOMETABOLIC DISEASE.

Lopez-Jaramillo P.

J Hypertens. 2016 Sep;34 Suppl 1 - ISH 2016 Abstract Book:e7.

PMID:
27753812
19.

The effect of weight loss magnitude on pro-/anti-inflammatory adipokines and carotid intima-media thickness in obese adolescents engaged in interdisciplinary weight loss therapy.

Masquio DC, de Piano A, Sanches PL, Corgosinho FC, Campos RM, Carnier J, da Silva PL, Caranti DA, Tock L, Oyama LM, Oller do Nascimento CM, de Mello MT, Tufik S, Dâmaso AR.

Clin Endocrinol (Oxf). 2013 Jul;79(1):55-64. doi: 10.1111/j.1365-2265.2012.04504.x. Epub 2013 Mar 25.

PMID:
22809141
20.

Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents.

Dâmaso AR, do Prado WL, de Piano A, Tock L, Caranti DA, Lofrano MC, Carnier J, Cristofalo DJ, Lederman H, Tufik S, de Mello MT.

Dig Liver Dis. 2008 Feb;40(2):132-9. Epub 2007 Dec 21.

PMID:
18082476

Supplemental Content

Support Center